Clinical Trials Directory

Trials / Completed

CompletedNCT02610036

Obliterating Diabetic Microangiopathy of the Diabetic Foot

Pilot Study on the Presence of Microangiopathy in Diabetic Foot Ulcer

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
IRCCS Multimedica · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study will be the assessment of microangiopathy determined by the increase of capillary basement membrane thickness and decrease of capillary lumen area in the foot ulcer of 30 neuropathic and 30 neuroischemic type 2 diabetic patients

Detailed description

Primary endpoint of the study is to quantitatively evaluate the presence of microangiopathy as increase of capillary basement membrane thickness and decrease of capillary lumen area determined by transmission electron microscopy analysis in type 2 diabetic patients with only motor-sensory neuropathy or chronic critical ischemia affected by foot ulcer. The following parameters will be evaluated: * presence of capillary (n/mm2) and thrombosis (%) and correlation of this quantitative histological data with ischemic parameters (TcPO2, ankle-brachial index) and risk of diastasis * correlation between presence of inflammatory infiltrate (leukocytes/mm2) with blood inflammatory parameters (erythrocyte sedimentation rate (ESR), C-reactive protein, alpha-2 globulin) * rate of diastasis and/or time required for recovery associated with histopathological data * presence of acanthosis related to clinical and demographic variables

Conditions

Timeline

Start date
2012-03-01
Primary completion
2012-11-01
Completion
2013-10-01
First posted
2015-11-20
Last updated
2015-11-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02610036. Inclusion in this directory is not an endorsement.